Medican Enterprises Stock Analysis

MDCN Stock  USD 0.0001  0.00  0.00%   
Medican Enterprises is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Medican Enterprises pink sheet analysis is to determine its intrinsic value, which is an estimate of what Medican Enterprises is worth, separate from its market price. There are two main types of Medican Enterprises' stock analysis: fundamental analysis and technical analysis.
The Medican Enterprises pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medican Enterprises. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Medican Pink Sheet Analysis Notes

The company recorded a loss per share of 17.92. Medican Enterprises had not issued any dividends in recent years. The entity had 1:10 split on the 20th of April 2015. Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada. Medican Enterprises operates under Real Estate Services classification in the United States and is traded on OTC Exchange. It employs 3 people.The quote for Medican Enterprises is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Medican Enterprises contact Kelvin Lindsey at 800-416-8802 or learn more at https://www.medicaninc.com.

Medican Enterprises Investment Alerts

Medican Enterprises is way too risky over 90 days horizon
Medican Enterprises has some characteristics of a very speculative penny stock
Medican Enterprises appears to be risky and price may revert if volatility continues
Medican Enterprises has high likelihood to experience some financial distress in the next 2 years
The company has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Medican Enterprises until it has trouble settling it off, either with new capital or with free cash flow. So, Medican Enterprises' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medican Enterprises sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medican to invest in growth at high rates of return. When we think about Medican Enterprises' use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (56.52 M) with profit before overhead, payroll, taxes, and interest of 0.
Medican Enterprises currently holds about 9.4 K in cash with (2.98 M) of positive cash flow from operations.

Medican Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 13.48 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medican Enterprises's market, we take the total number of its shares issued and multiply it by Medican Enterprises's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medican Enterprises, as well as the relationship between them.

Medican Enterprises Price Movement Analysis

java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Medican Enterprises middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Medican Enterprises. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Medican Enterprises Outstanding Bonds

Medican Enterprises issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medican Enterprises uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medican bonds can be classified according to their maturity, which is the date when Medican Enterprises has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

About Medican Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Medican Enterprises prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medican shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Medican Enterprises. By using and applying Medican Pink Sheet analysis, traders can create a robust methodology for identifying Medican entry and exit points for their positions.
Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada. Medican Enterprises operates under Real Estate Services classification in the United States and is traded on OTC Exchange. It employs 3 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Medican Enterprises to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Other Information on Investing in Medican Pink Sheet

Medican Enterprises financial ratios help investors to determine whether Medican Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medican with respect to the benefits of owning Medican Enterprises security.